Explore more publications!

Florida Health Daily: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Florida Health Daily.

Press releases published on December 11, 2025

Groundbreaking 2D Code Delivers Universal Access to Usage Instructions, Meeting ADA Standards — No Internet Required
Ascension Recovery Services names Nick Motu VP Biz Dev, Darcy Brazzle VP Quality/Compliance & Paige Bottom VP Operations
WellnessSpace Brands Introduces PolarWave, a Groundbreaking Cold Plunge Experience Without Getting Wet
GetHairMD Expands South Florida Presence with the Addition of Dr. Peter Khamvongsa of Miami Institute for Women’s Health
Interior Designer Perla Lichi Reaches New Audiences with a Spiritually-Themed TV Show and a Popular Hip-Hop Song
Sienna Announces Offering of $250 Million of 3.524% Series F Senior Unsecured Debentures and Redemption of C$175 Million of Series B Senior Unsecured Debentures
Surgery Partners, Inc. Announces Pricing of Add-On Notes Offering
Cycle Pharmaceuticals to Acquire Applied Therapeutics
The Joint Corp. Signs Asset Purchase Agreement to Sell 22 Corporate Clinics in the Southeast and Delivers Notice to Terminate APA for 45 Clinics in California
Precision Measurement Technologies Announces Strategic Partnership with Posifa Technologies
Serina Therapeutics Strengthens Leadership Team with Appointment of Dr. Joshua Thomas as VP, Head of Chemistry
Crinetics Announces First Patient Dosed in Pivotal Adult Trial of Atumelnant in Congenital Adrenal Hyperplasia (CAH)
Terns Announces Closing of Public Offering of Common Stock, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
Dyne Therapeutics Announces Closing of Upsized Public Offering of Common Stock and Full Exercise by Underwriters of Option to Purchase Additional Shares
Oruka Therapeutics Announces New Board Member and Board Transition
Kestra Medical Technologies Reports Second Quarter Fiscal 2026 Financial Results
Nusano Receives “Best Companies to Work For” Award from Utah Business
Kymera Therapeutics Announces Closing of Upsized $602 Million Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
Tenaya Therapeutics Announces Rapid Resolution and Lifting of Clinical Hold for MyPEAK-1™ Phase 1b/2a Clinical Trial of TN-201 Gene Therapy
Tenaya Therapeutics Reports Positive Interim Data from Cohort 1 of RIDGE™-1 Phase 1b/2 Clinical Trial of TN-401 Gene Therapy for Adults with PKP2-associated ARVC

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions